<- Go home

Added to YB: 2025-01-07

Pitch date: 2025-01-06

SRT.F [bullish]

Sartorius Aktiengesellschaft

+7.3%

current return

Author Info

No bio for this author

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.

Market Cap

EUR 14.5B

Pitch Price

EUR 177.08

Price Target

N/A

Dividend

0.31%

EV/EBITDA

20.60

P/E

N/A

EV/Sales

5.45

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
Sartorius Q4 2024: JPMorgan Forecasts Solid Revenue Growth and Profitable EBITDA Performance

SRT.F: JPM expects €705m BPS orders in Q4'24 (+14% QoQ), driven by strong consumables demand offsetting weak equipment orders. Forecasts solid CER revenue growth, profitable EBITDA growth for 2025. Places SRT/DIM on Positive Catalyst Watch for Q4 results (Jan 28), expecting EBITDA beat & achievable 2025 guidance.

Read full article (2 min)